Healthcare Sector Stocks
The Healthcare sector has a total of 1056 stocks, with a combined market cap of $8.94 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 44.83.
Market Cap
8.94T
Revenue
4.59T
Profits
199.33B
PE Ratio
44.83
Profit Margin
4.34%
Dividend Yield
0.40%
1057 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.06T | 5.81% | 1,479,216 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 610.21B | 3.52% | 3,069,671 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 438.69B | 2.12% | 1,604,774 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 387.01B | 2.56% | 1,921,763 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 317.99B | 2.63% | 2,576,145 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 288.22B | 1.67% | 765,478 | 60.44B |
| 7 | NVS | Novartis AG | 284.99B | 0.18% | 1,239,203 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 212.99B | 1.51% | 3,482,854 | 50.57B |
| 9 | AMGN | Amgen Inc. | 194.58B | 2.19% | 378,351 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 188.97B | 0.54% | 572,147 | 45.20B |
| 11 | ABT | Abbott Laboratories | 165.12B | 1.67% | 1,803,771 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 158.39B | 3.01% | 1,184,453 | 29.74B |
| 13 | ISRG | Intuitive Surgical, Inc. | 144.12B | 1.81% | 460,663 | 10.58B |
| 14 | DHR | Danaher Corporation | 138.21B | 1.07% | 549,435 | 24.78B |
| 15 | PFE | Pfizer Inc. | 137.87B | 2.20% | 10,119,858 | 63.32B |
| 16 | CVS | CVS Health Corporation | 135.32B | 1.34% | 1,565,956 | 405.62B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 126.74B | 3.99% | 428,286 | 12.22B |
| 18 | SYK | Stryker Corporation | 126.24B | 4.17% | 615,862 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 117.79B | 4.13% | 2,115,411 | 48.48B |
| 20 | GSK | GSK plc | 104.44B | 1.39% | 1,570,629 | 43.29B |
| 21 | MDT | Medtronic plc | 103.75B | 0.66% | 1,351,241 | 36.36B |
| 22 | SNY | Sanofi | 100.78B | 1.42% | 2,407,830 | 54.60B |
| 23 | MCK | McKesson Corporation | 91.25B | 2.04% | 128,592 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 86.73B | 1.04% | 157,795 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 85.68B | 1.87% | 253,096 | 200.42B |
| 26 | CI | The Cigna Group | 76.37B | 2.42% | 295,818 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 67.02B | 2.01% | 3,872,514 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 64.73B | 2.60% | 144,243 | 14.92B |
| 29 | COR | Cencora, Inc. | 56.66B | 1.48% | 232,176 | 328.68B |
| 30 | CAH | Cardinal Health, Inc. | 56.10B | 2.04% | 214,305 | 250.74B |
| 31 | ARGX | argenx SE | 55.35B | 1.06% | 104,668 | 4.74B |
| 32 | EW | Edwards Lifesciences Corporation | 52.33B | 1.30% | 508,378 | 6.30B |
| 33 | MDLN | Medline Inc. | 50.35B | 1.48% | 1,175,571 | 29.14B |
| 34 | TAK | Takeda Pharmaceutical Company Limited | 49.72B | 1.98% | 428,755 | 28.34B |
| 35 | HUM | Humana Inc. | 46.28B | 2.52% | 176,033 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 43.98B | 0.46% | 88,132 | 4.45B |
| 37 | BDX | Becton, Dickinson and Company | 42.98B | 3.05% | 1,144,150 | 22.23B |
| 38 | HLN | Haleon plc | 40.57B | 0.11% | 3,485,083 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.05B | 2.31% | 129,907 | 4.29B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 39.47B | 0.83% | 694,351 | 17.35B |
| 41 | A | Agilent Technologies, Inc. | 38.61B | 0.88% | 295,792 | 7.23B |
| 42 | NTRA | Natera, Inc. | 38.13B | 2.10% | 504,007 | 2.50B |
| 43 | RVMD | Revolution Medicines, Inc. | 38.10B | 0.58% | 561,954 | - |
| 44 | WAT | Waters Corporation | 36.81B | -0.53% | 98,530 | 3.77B |
| 45 | ALC | Alcon Inc. | 33.59B | 0.15% | 263,021 | 10.63B |
| 46 | ZTS | Zoetis Inc. | 32.18B | -1.36% | 996,477 | 9.53B |
| 47 | CNC | Centene Corporation | 32.18B | 0.60% | 727,798 | 178.33B |
| 48 | RPRX | Royalty Pharma plc | 31.47B | -0.05% | 379,803 | 2.44B |
| 49 | IQV | IQVIA Holdings Inc. | 31.39B | 0.88% | 178,870 | 16.63B |
| 50 | BIIB | Biogen Inc. | 31.23B | 4.74% | 407,926 | 9.94B |
| 51 | ONC | BeOne Medicines AG | 31.05B | 1.43% | 82,957 | 5.70B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 29.93B | 1.31% | 558,920 | 20.98B |
| 53 | RMD | ResMed Inc. | 28.88B | 0.70% | 139,525 | 5.54B |
| 54 | VEEV | Veeva Systems Inc. | 26.96B | 4.97% | 336,077 | 3.32B |
| 55 | ILMN | Illumina, Inc. | 26.85B | -0.11% | 324,154 | 4.39B |
| 56 | DXCM | DexCom, Inc. | 26.65B | 0.60% | 767,841 | 4.82B |
| 57 | MRNA | Moderna, Inc. | 26.55B | 11.97% | 3,275,387 | 2.23B |
| 58 | PHG | Koninklijke Philips N.V. | 25.94B | -0.84% | 207,731 | 20.34B |
| 59 | MTD | Mettler-Toledo International Inc. | 25.56B | 1.74% | 41,550 | 4.09B |
| 60 | ROIV | Roivant Sciences Ltd. | 24.61B | 0.59% | 1,452,926 | 8.26M |
| 61 | WST | West Pharmaceutical Services, Inc. | 24.51B | 0.12% | 109,373 | 3.22B |
| 62 | UTHR | United Therapeutics Corporation | 23.28B | 0.92% | 58,694 | 3.17B |
| 63 | INSM | Insmed Incorporated | 23.19B | 2.42% | 389,888 | 819.56M |
| 64 | DGX | Quest Diagnostics Incorporated | 22.95B | 0.51% | 93,048 | 11.28B |
| 65 | BNTX | BioNTech SE | 22.84B | 0.36% | 119,400 | 3.23B |
| 66 | INCY | Incyte Corporation | 22.84B | 6.31% | 832,748 | 5.36B |
| 67 | LH | Labcorp Holdings Inc. | 21.89B | 0.24% | 65,317 | 14.14B |
| 68 | STE | STERIS plc | 20.90B | 1.83% | 104,107 | 5.94B |
| 69 | GH | Guardant Health, Inc. | 19.59B | 3.37% | 527,824 | 1.08B |
| 70 | VTRS | Viatris Inc. | 18.99B | 1.49% | 1,212,743 | 14.56B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 17.95B | 2.02% | 224,116 | 8.41B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 16.90B | 2.39% | 169,512 | 3.10B |
| 73 | ASND | Ascendis Pharma A/S | 16.62B | 2.27% | 228,492 | 998.25M |
| 74 | GMAB | Genmab A/S | 16.10B | -0.80% | 551,961 | 3.90B |
| 75 | THC | Tenet Healthcare Corporation | 15.74B | -0.67% | 171,732 | 21.46B |
| 76 | MEDP | Medpace Holdings, Inc. | 14.90B | 0.36% | 58,014 | 2.68B |
| 77 | BTSG | BrightSpring Health Services, Inc. | 14.67B | 1.02% | 551,668 | 13.65B |
| 78 | JAZZ | Jazz Pharmaceuticals plc | 14.45B | 1.78% | 81,656 | 4.44B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 14.02B | 2.74% | 996,342 | 579.96M |
| 80 | COO | The Cooper Companies, Inc. | 13.97B | 1.37% | 300,344 | 4.23B |
| 81 | SOLV | Solventum Corporation | 13.88B | 2.85% | 150,357 | 8.26B |
| 82 | EXEL | Exelixis, Inc. | 13.75B | 2.80% | 377,226 | 2.38B |
| 83 | DVA | DaVita Inc. | 13.73B | 0.22% | 81,038 | 13.84B |
| 84 | IONS | Ionis Pharmaceuticals, Inc. | 13.40B | 3.51% | 952,050 | 1.06B |
| 85 | SNN | Smith & Nephew plc | 12.85B | -0.33% | 441,243 | 6.16B |
| 86 | RVTY | Revvity, Inc. | 12.84B | 1.36% | 364,686 | 2.90B |
| 87 | ICLR | ICON Public Limited Company | 12.73B | 3.24% | 190,574 | 8.27B |
| 88 | PEN | Penumbra, Inc. | 12.54B | 0.47% | 47,104 | 1.45B |
| 89 | ALGN | Align Technology, Inc. | 12.53B | -0.46% | 68,838 | 4.10B |
| 90 | AXSM | Axsome Therapeutics, Inc. | 12.50B | 2.39% | 248,416 | 708.24M |
| 91 | FMS | Fresenius Medical Care AG | 12.50B | 0.19% | 106,439 | 22.32B |
| 92 | ELAN | Elanco Animal Health Incorporated | 12.48B | 2.54% | 813,437 | 4.89B |
| 93 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.17B | 2.74% | 31,841 | 1.13B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 11.91B | 2.36% | 607,292 | 3.58B |
| 95 | GMED | Globus Medical, Inc. | 11.59B | 0.89% | 292,482 | 3.10B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 11.50B | 3.75% | 399,345 | 3.24B |
| 97 | MOH | Molina Healthcare, Inc. | 11.45B | 1.72% | 194,592 | 43.10B |
| 98 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.40B | 2.07% | 279,149 | 622.01M |
| 99 | BAX | Baxter International Inc. | 11.38B | 2.20% | 1,276,348 | 11.32B |
| 100 | CYTK | Cytokinetics, Incorporated | 11.35B | 3.50% | 609,081 | 105.82M |
| 101 | TECH | Bio-Techne Corporation | 11.12B | 0.50% | 3,475,286 | 1.21B |
| 102 | SMMT | Summit Therapeutics Inc. | 11.02B | 0.14% | 509,541 | - |
| 103 | PODD | Insulet Corporation | 11.00B | 3.28% | 308,890 | 2.90B |
| 104 | KRYS | Krystal Biotech, Inc. | 10.91B | 2.81% | 46,376 | 417.30M |
| 105 | CRL | Charles River Laboratories International, Inc. | 10.26B | 0.13% | 200,625 | 4.03B |
| 106 | EHC | Encompass Health Corporation | 10.03B | 1.41% | 309,736 | 6.07B |
| 107 | TEM | Tempus AI, Inc. | 9.99B | 1.35% | 2,826,207 | 1.36B |
| 108 | APGE | Apogee Therapeutics, Inc. | 9.94B | - | 1,064,201 | - |
| 109 | NUVL | Nuvalent, Inc. | 9.76B | 0.01% | 267,175 | - |
| 110 | HSIC | Henry Schein, Inc. | 9.66B | 1.36% | 176,169 | 13.38B |
| 111 | KYMR | Kymera Therapeutics, Inc. | 9.64B | 0.64% | 328,413 | 51.48M |
| 112 | ENSG | The Ensign Group, Inc. | 9.51B | -1.04% | 191,752 | 5.27B |
| 113 | CORT | Corcept Therapeutics Incorporated | 9.34B | 2.69% | 127,321 | 769.10M |
| 114 | ALKS | Alkermes plc | 9.18B | 4.30% | 610,663 | 1.56B |
| 115 | PRAX | Praxis Precision Medicines, Inc. | 9.11B | -0.37% | 178,446 | 7.46M |
| 116 | BRKR | Bruker Corporation | 9.10B | -1.81% | 197,977 | 3.46B |
| 117 | HALO | Halozyme Therapeutics, Inc. | 8.96B | 3.99% | 369,279 | 1.51B |
| 118 | OSCR | Oscar Health, Inc. | 8.94B | 3.59% | 1,084,683 | 13.30B |
| 119 | UHS | Universal Health Services, Inc. | 8.81B | 0.80% | 43,234 | 17.76B |
| 120 | IBRX | ImmunityBio, Inc. | 8.39B | 2.82% | 3,156,807 | 140.98M |
| 121 | GKOS | Glaukos Corporation | 8.37B | -0.01% | 81,701 | 551.35M |
| 122 | RGEN | Repligen Corporation | 8.27B | 0.96% | 189,456 | 763.34M |
| 123 | PCVX | Vaxcyte, Inc. | 8.11B | 4.66% | 282,120 | - |
| 124 | QGEN | Qiagen N.V. | 8.06B | 0.13% | 420,761 | 2.10B |
| 125 | ATR | AptarGroup, Inc. | 8.05B | -0.23% | 36,823 | 3.87B |
| 126 | BIO | Bio-Rad Laboratories, Inc. | 7.99B | 0.04% | 30,377 | 2.59B |
| 127 | HIMS | Hims & Hers Health, Inc. | 7.93B | 4.80% | 6,724,894 | 2.37B |
| 128 | IMVT | Immunovant, Inc. | 7.88B | 0.37% | 147,959 | - |
| 129 | PTGX | Protagonist Therapeutics, Inc. | 7.83B | -0.77% | 126,381 | 74.06M |
| 130 | SYRE | Spyre Therapeutics, Inc. | 7.73B | 0.37% | 237,643 | - |
| 131 | TGTX | TG Therapeutics, Inc. | 7.67B | 0.86% | 336,376 | 700.35M |
| 132 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.54B | 1.69% | 115,747 | 217.17M |
| 133 | MIRM | Mirum Pharmaceuticals, Inc. | 7.38B | 3.12% | 300,442 | 569.61M |
| 134 | ABVX | ABIVAX Société Anonyme | 7.30B | 3.85% | 566,364 | 5.67M |
| 135 | HQY | HealthEquity, Inc. | 7.21B | 3.44% | 114,082 | 1.34B |
| 136 | LNTH | Lantheus Holdings, Inc. | 7.17B | 0.99% | 58,329 | 1.55B |
| 137 | PTCT | PTC Therapeutics, Inc. | 7.08B | 0.99% | 190,997 | 827.11M |
| 138 | AVTR | Avantor, Inc. | 7.03B | 2.18% | 1,357,048 | 6.55B |
| 139 | LQDA | Liquidia Corporation | 6.98B | 1.99% | 289,776 | 288.07M |
| 140 | SRRK | Scholar Rock Holding Corporation | 6.55B | 1.69% | 593,386 | - |
| 141 | CGON | CG Oncology, Inc. | 6.46B | 0.62% | 156,533 | 5.07M |
| 142 | COGT | Cogent Biosciences, Inc. | 6.38B | -1.79% | 420,402 | - |
| 143 | PACS | PACS Group, Inc. | 6.37B | -1.13% | 95,235 | 5.43B |
| 144 | TWST | Twist Bioscience Corporation | 6.29B | 4.44% | 699,578 | 409.48M |
| 145 | GRFS | Grifols, S.A. | 6.27B | 1.56% | 74,439 | 8.58B |
| 146 | CHE | Chemed Corporation | 6.03B | 0.74% | 32,703 | 2.54B |
| 147 | BLTE | Belite Bio, Inc | 5.99B | 1.69% | 67,115 | - |
| 148 | HNGE | Hinge Health, Inc. | 5.96B | 2.54% | 349,356 | 646.34M |
| 149 | LGND | Ligand Pharmaceuticals Incorporated | 5.92B | -0.24% | 55,720 | 274.48M |
| 150 | BLCO | Bausch + Lomb Corporation | 5.82B | 2.58% | 143,617 | 5.21B |
| 151 | TFX | Teleflex Incorporated | 5.81B | 2.72% | 57,289 | 2.13B |
| 152 | AMRX | Amneal Pharmaceuticals, Inc. | 5.68B | 2.71% | 254,452 | 3.05B |
| 153 | XENE | Xenon Pharmaceuticals Inc. | 5.60B | 1.97% | 284,576 | 7.50M |
| 154 | TVTX | Travere Therapeutics, Inc. | 5.52B | 0.58% | 223,562 | 536.20M |
| 155 | CAI | Caris Life Sciences, Inc. | 5.42B | 2.57% | 839,371 | 907.29M |
| 156 | CRSP | CRISPR Therapeutics AG | 5.34B | 2.54% | 551,015 | 4.10M |
| 157 | LEGN | Legend Biotech Corporation | 5.30B | 0.42% | 397,143 | 1.14B |
| 158 | ORKA | Oruka Therapeutics, Inc. | 5.27B | 0.81% | 205,112 | - |
| 159 | BLLN | BillionToOne, Inc. | 5.26B | 1.94% | 205,350 | 354.54M |
| 160 | INDV | Indivior Pharmaceuticals, Inc. | 5.19B | 3.09% | 475,730 | 1.29B |
| 161 | DNTH | Dianthus Therapeutics, Inc. | 5.04B | 0.66% | 185,231 | 1.34M |
| 162 | STVN | Stevanato Group S.p.A. | 5.02B | 0.05% | 33,822 | 1.39B |
| 163 | SHC | Sotera Health Company | 4.94B | 1.32% | 211,819 | 1.19B |
| 164 | MANE | Veradermics, Incorporated | 4.93B | -1.15% | 115,872 | - |
| 165 | DFTX | Definium Therapeutics, Inc. | 4.91B | 0.47% | 846,135 | - |
| 166 | CELC | Celcuity Inc. | 4.80B | 2.51% | 145,961 | - |
| 167 | ALHC | Alignment Healthcare, Inc. | 4.79B | 2.05% | 482,958 | 4.26B |
| 168 | RDNT | RadNet, Inc. | 4.77B | 1.07% | 94,989 | 2.14B |
| 169 | VCYT | Veracyte, Inc. | 4.75B | 1.61% | 183,090 | 541.74M |
| 170 | ERAS | Erasca, Inc. | 4.72B | 1.54% | 1,113,591 | - |
| 171 | TXG | 10x Genomics, Inc. | 4.57B | 0.84% | 290,458 | 638.78M |
| 172 | LIVN | LivaNova PLC | 4.56B | 2.53% | 116,828 | 1.43B |
| 173 | EWTX | Edgewise Therapeutics, Inc. | 4.54B | 1.10% | 57,847 | - |
| 174 | ACAD | ACADIA Pharmaceuticals Inc. | 4.53B | 11.55% | 1,554,632 | 1.10B |
| 175 | TNGX | Tango Therapeutics, Inc. | 4.45B | 2.06% | 1,501,594 | 56.99M |
| 176 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.44B | 1.42% | 65,996 | 754.05M |
| 177 | VKTX | Viking Therapeutics, Inc. | 4.35B | 1.35% | 794,963 | - |
| 178 | NVST | Envista Holdings Corporation | 4.34B | - | 377,891 | 2.81B |
| 179 | MMSI | Merit Medical Systems, Inc. | 4.31B | 2.12% | 91,122 | 1.54B |
| 180 | MMED | MiniMed Group, Inc. | 4.06B | 1.55% | 165,381 | 3.10B |
| 181 | RLAY | Relay Therapeutics, Inc. | 3.99B | 2.69% | 1,006,759 | 10.68M |
| 182 | DNLI | Denali Therapeutics Inc. | 3.98B | 1.50% | 420,529 | - |
| 183 | IRTC | iRhythm Holdings, Inc. | 3.95B | 3.53% | 113,776 | 787.85M |
| 184 | RCUS | Arcus Biosciences, Inc. | 3.88B | 1.98% | 264,472 | 236.00M |
| 185 | NAMS | NewAmsterdam Pharma Company N.V. | 3.88B | 4.54% | 204,441 | 22.57M |
| 186 | LFST | LifeStance Health Group, Inc. | 3.87B | 1.01% | 420,293 | 1.49B |
| 187 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.85B | 4.29% | 474,944 | 18.07M |
| 188 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | -0.02% | 208,602 | 596.96M |
| 189 | CON | Concentra Group Holdings Parent, Inc. | 3.83B | 1.11% | 56,523 | 2.23B |
| 190 | WAY | Waystar Holding Corp. | 3.78B | 3.85% | 259,560 | 1.16B |
| 191 | ICUI | ICU Medical, Inc. | 3.78B | 1.48% | 29,825 | 2.16B |
| 192 | BKD | Brookdale Senior Living Inc. | 3.74B | 1.56% | 798,764 | 3.00B |
| 193 | DOCS | Doximity, Inc. | 3.74B | 2.92% | 1,052,605 | 644.86M |
| 194 | HAE | Haemonetics Corporation | 3.63B | 2.83% | 145,597 | 1.33B |
| 195 | TLX | Telix Pharmaceuticals Limited | 3.60B | -1.47% | 17,430 | 803.79M |
| 196 | OGN | Organon & Co. | 3.54B | 0.11% | 168,835 | 6.16B |
| 197 | BEAM | Beam Therapeutics Inc. | 3.52B | 4.35% | 436,046 | 164.01M |
| 198 | GPCR | Structure Therapeutics Inc. | 3.51B | 2.50% | 130,768 | - |
| 199 | DYN | Dyne Therapeutics, Inc. | 3.49B | 2.52% | 701,342 | - |
| 200 | WRBY | Warby Parker Inc. | 3.46B | 2.55% | 237,378 | 890.57M |
| 201 | PBLS | Parabilis Medicines, Inc. | 3.42B | 2.01% | 37,985 | - |
| 202 | OPCH | Option Care Health, Inc. | 3.40B | 0.70% | 243,743 | 5.67B |
| 203 | ARQT | Arcutis Biotherapeutics, Inc. | 3.36B | 0.52% | 153,273 | 415.62M |
| 204 | ALMS | Alumis Inc. | 3.32B | 4.04% | 384,172 | 8.40M |
| 205 | RGC | Regencell Bioscience Holdings Limited | 3.31B | -10.68% | 131,021 | - |
| 206 | ADPT | Adaptive Biotechnologies Corporation | 3.31B | 2.27% | 507,813 | 295.41M |
| 207 | IDYA | IDEAYA Biosciences, Inc. | 3.24B | 1.63% | 355,807 | 225.27M |
| 208 | ITGR | Integer Holdings Corporation | 3.19B | 1.01% | 20,320 | 1.86B |
| 209 | PRVA | Privia Health Group, Inc. | 3.17B | 2.69% | 115,416 | 2.25B |
| 210 | NHC | National HealthCare Corporation | 3.15B | 0.14% | 50,130 | 1.53B |
| 211 | HTFL | HeartFlow, Inc. | 3.07B | 1.77% | 183,070 | 191.42M |
| 212 | ELVN | Enliven Therapeutics, Inc. | 3.04B | 1.47% | 340,752 | - |
| 213 | VERA | Vera Therapeutics, Inc. | 3.02B | 3.83% | 517,933 | - |
| 214 | QURE | uniQure N.V. | 3.00B | -3.05% | 761,227 | 18.09M |
| 215 | RARE | Ultragenyx Pharmaceutical Inc. | 2.98B | 3.79% | 373,063 | 670.00M |
| 216 | CLOV | Clover Health Investments, Corp. | 2.84B | 3.45% | 1,833,737 | 2.21B |
| 217 | GRAL | GRAIL, Inc. | 2.83B | -0.86% | 74,570 | 156.12M |
| 218 | TARS | Tarsus Pharmaceuticals, Inc. | 2.83B | 2.28% | 154,238 | 535.08M |
| 219 | IRON | Disc Medicine, Inc. | 2.78B | 3.61% | 180,021 | - |
| 220 | CLDX | Celldex Therapeutics, Inc. | 2.70B | 1.09% | 103,953 | 865.00K |
| 221 | SUPN | Supernus Pharmaceuticals, Inc. | 2.64B | 1.54% | 65,577 | 776.83M |
| 222 | KLRA | Kailera Therapeutics, Inc. | 2.61B | -2.32% | 107,923 | - |
| 223 | ESTA | Establishment Labs Holdings Inc. | 2.61B | -0.34% | 186,277 | 229.58M |
| 224 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.56B | 1.92% | 1,032,321 | 885.72M |
| 225 | GRDN | Guardian Pharmacy Services, Inc. | 2.54B | 3.32% | 69,816 | 1.46B |
| 226 | TRVI | Trevi Therapeutics, Inc. | 2.52B | -1.22% | 362,486 | - |
| 227 | MBX | MBX Biosciences, Inc. | 2.50B | 4.11% | 112,222 | - |
| 228 | BHVN | Biohaven Ltd. | 2.48B | 7.17% | 1,627,192 | - |
| 229 | ACHC | Acadia Healthcare Company, Inc. | 2.44B | 0.95% | 303,210 | 3.37B |
| 230 | NRIX | Nurix Therapeutics, Inc. | 2.39B | 2.98% | 696,081 | 71.78M |
| 231 | PHVS | Pharvaris N.V. | 2.36B | 1.59% | 90,436 | - |
| 232 | AXGN | Axogen, Inc. | 2.36B | -0.29% | 279,938 | 238.11M |
| 233 | TMDX | TransMedics Group, Inc. | 2.35B | -12.64% | 954,546 | 635.89M |
| 234 | NTLA | Intellia Therapeutics, Inc. | 2.33B | 4.18% | 1,381,431 | 66.09M |
| 235 | IMNM | Immunome, Inc. | 2.29B | 4.12% | 309,728 | 4.02M |
| 236 | PBH | Prestige Consumer Healthcare Inc. | 2.28B | 1.80% | 26,166 | 1.09B |
| 237 | VCEL | Vericel Corporation | 2.24B | 2.19% | 134,865 | 292.09M |
| 238 | AUPH | Aurinia Pharmaceuticals Inc. | 2.21B | -1.99% | 309,060 | 298.30M |
| 239 | BHC | Bausch Health Companies Inc. | 2.20B | 11.55% | 5,170,690 | 10.53B |
| 240 | XRAY | DENTSPLY SIRONA Inc. | 2.20B | 1.86% | 537,175 | 3.68B |
| 241 | KOD | Kodiak Sciences Inc. | 2.20B | 3.15% | 144,546 | - |
| 242 | ASTH | Astrana Health, Inc. | 2.19B | 1.63% | 54,621 | 3.53B |
| 243 | BFLY | Butterfly Network, Inc. | 2.19B | 4.36% | 2,753,581 | 102.92M |
| 244 | PGNY | Progyny, Inc. | 2.18B | 1.73% | 112,334 | 1.29B |
| 245 | AGIO | Agios Pharmaceuticals, Inc. | 2.18B | 1.08% | 172,565 | 66.05M |
| 246 | SLS | SELLAS Life Sciences Group, Inc. | 2.17B | 10.92% | 5,007,092 | - |
| 247 | OCUL | Ocular Therapeutix, Inc. | 2.16B | 1.23% | 236,781 | 52.04M |
| 248 | MLYS | Mineralys Therapeutics, Inc. | 2.16B | -0.68% | 277,668 | - |
| 249 | LMAT | LeMaitre Vascular, Inc. | 2.15B | 0.06% | 37,393 | 256.28M |
| 250 | ABCL | AbCellera Biologics Inc. | 2.13B | 4.50% | 3,519,804 | 79.21M |
| 251 | NKTR | Nektar Therapeutics | 2.12B | 1.39% | 188,055 | 55.63M |
| 252 | GENB | Generate Biomedicines, Inc. | 2.12B | 0.67% | 164,091 | 30.30M |
| 253 | PGEN | Precigen, Inc. | 2.10B | 6.61% | 1,394,100 | 31.60M |
| 254 | NEOG | Neogen Corporation | 2.08B | 0.53% | 153,321 | 870.56M |
| 255 | WGS | GeneDx Holdings Corp. | 2.07B | 1.78% | 131,110 | 442.68M |
| 256 | SEM | Select Medical Holdings Corporation | 2.05B | 0.06% | 350,169 | 5.52B |
| 257 | ADMA | ADMA Biologics, Inc. | 2.05B | 1.32% | 282,600 | 509.86M |
| 258 | HRMY | Harmony Biosciences Holdings, Inc. | 2.03B | 2.87% | 44,403 | 899.11M |
| 259 | SGRY | Surgery Partners, Inc. | 2.03B | 1.23% | 208,964 | 3.34B |
| 260 | KARD | Kardigan, Inc. | 2.02B | 0.09% | 95,668 | - |
| 261 | UFPT | UFP Technologies, Inc. | 2.01B | 2.59% | 45,744 | 608.85M |
| 262 | STOK | Stoke Therapeutics, Inc. | 1.99B | 5.23% | 267,378 | 32.08M |
| 263 | VRDN | Viridian Therapeutics, Inc. | 1.99B | 3.39% | 320,698 | 70.92M |
| 264 | PLSE | Pulse Biosciences, Inc. | 1.98B | 3.98% | 517,281 | 751.00K |
| 265 | PVLA | Palvella Therapeutics, Inc. | 1.98B | 1.13% | 70,718 | - |
| 266 | NUVB | Nuvation Bio Inc. | 1.97B | -2.50% | 9,135,184 | 143.05M |
| 267 | ZLAB | Zai Lab Limited | 1.96B | -5.83% | 706,470 | 453.28M |
| 268 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.96B | 0.86% | 341,744 | -665.00K |
| 269 | RAPP | Rapport Therapeutics, Inc. | 1.95B | 4.55% | 100,509 | 20.00M |
| 270 | CMPS | COMPASS Pathways plc | 1.94B | 5.74% | 973,247 | - |
| 271 | MD | Pediatrix Medical Group, Inc. | 1.94B | 0.17% | 73,445 | 1.93B |
| 272 | SION | Sionna Therapeutics, Inc. | 1.93B | -0.28% | 80,145 | - |
| 273 | IOVA | Iovance Biotherapeutics, Inc. | 1.91B | 1.66% | 2,303,698 | 285.61M |
| 274 | AVAH | Aveanna Healthcare Holdings Inc. | 1.91B | 3.42% | 338,546 | 2.52B |
| 275 | TYRA | Tyra Biosciences, Inc. | 1.90B | 3.49% | 87,032 | - |
| 276 | LKFT | Lakefront Biotherapeutics NV | 1.90B | 2.25% | 23,965 | 1.20B |
| 277 | ALMR | Alamar Biosciences, Inc. | 1.86B | -0.11% | 52,510 | 87.16M |
| 278 | RXRX | Recursion Pharmaceuticals, Inc. | 1.85B | 4.49% | 6,643,048 | 66.41M |
| 279 | AGL | agilon health, inc. | 1.85B | 3.41% | 54,506 | 5.82B |
| 280 | ATAI | AtaiBeckley Inc. | 1.84B | 9.17% | 3,272,561 | 3.49M |
| 281 | SNDA | Sonida Senior Living, Inc. | 1.84B | 0.38% | 63,275 | 367.34M |
| 282 | GLUE | Monte Rosa Therapeutics, Inc. | 1.84B | 0.39% | 218,477 | 42.95M |
| 283 | TSHA | Taysha Gene Therapies, Inc. | 1.82B | 1.93% | 599,526 | 7.47M |
| 284 | HCM | HUTCHMED (China) Limited | 1.80B | -0.39% | 13,299 | 548.51M |
| 285 | GHRS | GH Research PLC | 1.80B | 3.59% | 30,371 | - |
| 286 | SNDX | Syndax Pharmaceuticals, Inc. | 1.80B | 2.47% | 295,454 | 217.17M |
| 287 | NVCR | NovoCure Limited | 1.80B | 2.99% | 118,673 | 674.41M |
| 288 | AKTS | Aktis Oncology, Inc. | 1.79B | 4.11% | 88,790 | 8.28M |
| 289 | ANIP | ANI Pharmaceuticals, Inc. | 1.79B | 1.43% | 45,055 | 923.71M |
| 290 | NEO | NeoGenomics, Inc. | 1.78B | -0.40% | 304,972 | 745.97M |
| 291 | ANAB | AnaptysBio, Inc. | 1.78B | 2.51% | 31,926 | 232.39M |
| 292 | ADUS | Addus HomeCare Corporation | 1.77B | 0.21% | 16,270 | 1.45B |
| 293 | OMCL | Omnicell, Inc. | 1.77B | -1.47% | 84,943 | 1.23B |
| 294 | ZYME | Zymeworks Inc. | 1.77B | 1.89% | 48,359 | 81.26M |
| 295 | BCAX | Bicara Therapeutics Inc. | 1.76B | 1.86% | 120,038 | - |
| 296 | INVA | Innoviva, Inc. | 1.75B | 1.78% | 44,577 | 420.69M |
| 297 | VIR | Vir Biotechnology, Inc. | 1.73B | 4.05% | 253,593 | 65.50M |
| 298 | NBTX | Nanobiotix S.A. | 1.73B | 3.95% | 5,652 | 38.27M |
| 299 | ABSI | Absci Corporation | 1.71B | 7.15% | 3,473,002 | 1.84M |
| 300 | URGN | UroGen Pharma Ltd. | 1.70B | 1.77% | 78,666 | 140.49M |
| 301 | SRPT | Sarepta Therapeutics, Inc. | 1.70B | 0.72% | 371,857 | 2.18B |
| 302 | MESO | Mesoblast Limited | 1.69B | -8.34% | 170,263 | 65.38M |
| 303 | TRLV | Trulieve Cannabis Corp. | 1.68B | 2.46% | 317,100 | 1.17B |
| 304 | HCSG | Healthcare Services Group, Inc. | 1.65B | 1.57% | 57,779 | 1.85B |
| 305 | SEPN | Septerna, Inc. | 1.63B | 4.95% | 79,633 | 72.26M |
| 306 | FTRE | Fortrea Holdings Inc. | 1.63B | -2.80% | 304,281 | 2.71B |
| 307 | IMCR | Immunocore Holdings plc | 1.60B | 3.06% | 84,998 | 412.81M |
| 308 | AVBP | ArriVent BioPharma, Inc. | 1.59B | 0.93% | 134,525 | - |
| 309 | ZBIO | Zenas BioPharma, Inc. | 1.56B | 0.20% | 254,339 | 10.00M |
| 310 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.56B | -1.31% | 469,212 | 204.73M |
| 311 | HROW | Harrow, Inc. | 1.56B | 0.70% | 68,215 | 268.68M |
| 312 | SVRA | Savara Inc. | 1.56B | 1.82% | 498,096 | - |
| 313 | CAPR | Capricor Therapeutics, Inc. | 1.52B | -13.45% | 870,724 | 11.13M |
| 314 | MPLT | MapLight Therapeutics, Inc. | 1.52B | 4.63% | 87,937 | - |
| 315 | STAA | STAAR Surgical Company | 1.52B | -2.50% | 61,634 | 290.38M |
| 316 | MAZE | Maze Therapeutics, Inc. | 1.50B | 0.50% | 76,579 | 20.00M |
| 317 | CDNA | CareDx, Inc. | 1.49B | 3.23% | 135,243 | 412.82M |
| 318 | TDOC | Teladoc Health, Inc. | 1.47B | 3.03% | 925,026 | 2.51B |
| 319 | MLTX | MoonLake Immunotherapeutics | 1.47B | -0.30% | 217,791 | - |
| 320 | DMRA | Damora Therapeutics, Inc. | 1.46B | 5.14% | 92,774 | - |
| 321 | ATRC | AtriCure, Inc. | 1.45B | 2.12% | 127,102 | 552.16M |
| 322 | NVAX | Novavax, Inc. | 1.44B | 2.45% | 624,574 | 596.34M |
| 323 | INNV | InnovAge Holding Corp. | 1.44B | 2.32% | 71,935 | 949.17M |
| 324 | ARDX | Ardelyx, Inc. | 1.44B | -4.13% | 2,836,994 | 427.68M |
| 325 | IART | Integra LifeSciences Holdings Corporation | 1.43B | 1.66% | 56,428 | 1.64B |
| 326 | AAPG | Ascentage Pharma Group International | 1.43B | -1.85% | 173,224 | 82.08M |
| 327 | INBX | Inhibrx Biosciences, Inc. | 1.41B | 0.79% | 64,033 | 1.30M |
| 328 | KMTS | Kestra Medical Technologies, Ltd. | 1.40B | 6.16% | 37,456 | 83.72M |
| 329 | COAG | Hemab Therapeutics Holdings, Inc. | 1.40B | 8.01% | 20,694 | - |
| 330 | ARDT | Ardent Health, Inc. | 1.38B | 2.88% | 58,208 | 6.43B |
| 331 | ATEC | Alphatec Holdings, Inc. | 1.38B | 1.30% | 290,542 | 787.08M |
| 332 | BLFS | BioLife Solutions, Inc. | 1.37B | 1.78% | 92,477 | 101.66M |
| 333 | PRGO | Perrigo Company plc | 1.36B | 1.86% | 215,551 | 4.18B |
| 334 | PSNL | Personalis, Inc. | 1.35B | 2.54% | 1,459,484 | 64.52M |
| 335 | AHCO | AdaptHealth Corp. | 1.35B | 0.95% | 137,283 | 3.29B |
| 336 | IMTX | Immatics N.V. | 1.32B | 1.10% | 62,555 | 43.00M |
| 337 | XERS | Xeris Biopharma Holdings, Inc. | 1.31B | 2.70% | 407,745 | 314.85M |
| 338 | AVLN | Avalyn Pharma Inc. | 1.31B | 1.77% | 22,921 | - |
| 339 | JBIO | Jade Biosciences, Inc. | 1.31B | 0.96% | 141,504 | - |
| 340 | PAHC | Phibro Animal Health Corporation | 1.30B | 1.07% | 9,267 | 1.50B |
| 341 | AMN | AMN Healthcare Services, Inc. | 1.29B | 3.23% | 192,426 | 3.42B |
| 342 | ENOV | Enovis Corporation | 1.29B | 1.91% | 66,098 | 2.28B |
| 343 | SDGR | Schrödinger, Inc. | 1.28B | 6.38% | 823,557 | 254.91M |
| 344 | INSP | Inspire Medical Systems, Inc. | 1.27B | 1.75% | 95,870 | 915.25M |
| 345 | PNTG | The Pennant Group, Inc. | 1.27B | 1.63% | 35,129 | 1.02B |
| 346 | PRCT | PROCEPT BioRobotics Corporation | 1.27B | 3.54% | 268,323 | 322.02M |
| 347 | MNKD | MannKind Corporation | 1.26B | 3.82% | 836,115 | 360.78M |
| 348 | IRMD | IRADIMED CORPORATION | 1.21B | 1.04% | 7,775 | 86.28M |
| 349 | AHG | Akso Health Group | 1.21B | 5.22% | 1,663 | 14.84M |
| 350 | OPK | OPKO Health, Inc. | 1.19B | 4.30% | 1,479,284 | 581.12M |
| 351 | ALVO | Alvotech | 1.19B | 2.01% | 426,076 | 562.04M |
| 352 | COLL | Collegium Pharmaceutical, Inc. | 1.18B | 4.74% | 55,654 | 796.33M |
| 353 | CGEM | Cullinan Therapeutics, Inc. | 1.17B | 3.25% | 163,205 | - |
| 354 | OMDA | Omada Health, Inc. | 1.17B | 4.13% | 194,133 | 283.30M |
| 355 | AVNS | Avanos Medical, Inc. | 1.17B | - | 70,425 | 715.90M |
| 356 | EYPT | EyePoint, Inc. | 1.16B | 1.09% | 143,343 | 7.61M |
| 357 | AZTA | Azenta, Inc. | 1.16B | 1.75% | 59,586 | 596.48M |
| 358 | XNCR | Xencor, Inc. | 1.15B | 5.43% | 210,021 | 97.36M |
| 359 | WVE | Wave Life Sciences Ltd. | 1.15B | 3.83% | 356,389 | 71.80M |
| 360 | AORT | Artivion, Inc. | 1.15B | 4.26% | 147,089 | 458.69M |
| 361 | NUTX | Nutex Health Inc. | 1.12B | 9.10% | 46,000 | 879.95M |
| 362 | MGTX | MeiraGTx Holdings plc | 1.12B | 4.42% | 115,786 | 79.76M |
| 363 | CRVS | Corvus Pharmaceuticals, Inc. | 1.11B | 0.84% | 110,910 | - |
| 364 | TNDM | Tandem Diabetes Care, Inc. | 1.10B | 2.28% | 206,359 | 1.03B |
| 365 | LMRI | Lumexa Imaging Holdings, Inc. | 1.08B | 6.19% | 83,415 | 1.03B |
| 366 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.07B | 5.24% | 1,839,361 | 69.64M |
| 367 | CNMD | CONMED Corporation | 1.06B | 2.17% | 40,798 | 1.37B |
| 368 | SPTX | Seaport Therapeutics, Inc. | 1.05B | 1.34% | 13,533 | - |
| 369 | BIOA | BioAge Labs, Inc. | 1.05B | 4.42% | 206,858 | 10.32M |
| 370 | SANA | Sana Biotechnology, Inc. | 1.04B | 6.44% | 830,631 | - |
| 371 | USPH | U.S. Physical Therapy, Inc. | 1.03B | 2.15% | 28,547 | 787.69M |
| 372 | CRON | Cronos Group Inc. | 1.02B | 2.01% | 138,682 | 159.54M |
| 373 | DRTS | Alpha Tau Medical Ltd. | 1.01B | -0.09% | 204,961 | - |
| 374 | ORIC | ORIC Pharmaceuticals, Inc. | 999.98M | 2.11% | 324,145 | - |
| 375 | AVR | Anteris Technologies Global Corp. | 996.78M | 3.64% | 232,821 | 1.85M |
| 376 | OLMA | Olema Pharmaceuticals, Inc. | 994.01M | -0.44% | 714,710 | - |
| 377 | PCRX | Pacira BioSciences, Inc. | 989.21M | 3.16% | 87,305 | 734.86M |
| 378 | EVO | Evotec SE | 979.00M | 2.21% | 2,463 | 859.03M |
| 379 | ETON | Eton Pharmaceuticals, Inc. | 971.33M | 1.84% | 74,239 | 86.93M |
| 380 | QDEL | QuidelOrtho Corporation | 954.67M | 3.55% | 81,629 | 2.66B |
| 381 | DBVT | DBV Technologies S.A. | 950.00M | 0.56% | 28,982 | 5.74M |
| 382 | AMPH | Amphastar Pharmaceuticals, Inc. | 949.54M | 2.35% | 64,786 | 720.53M |
| 383 | AVTX | Avalo Therapeutics, Inc. | 944.08M | -0.22% | 260,673 | 59.00K |
| 384 | PHAR | Pharming Group N.V. | 941.11M | 0.19% | 2,257 | 369.49M |
| 385 | GDRX | GoodRx Holdings, Inc. | 939.82M | 3.16% | 97,771 | 787.89M |
| 386 | KURA | Kura Oncology, Inc. | 933.91M | 1.54% | 175,078 | 71.64M |
| 387 | JANX | Janux Therapeutics, Inc. | 930.01M | 4.60% | 731,441 | 13.73M |
| 388 | INMD | InMode Ltd. | 929.47M | -0.95% | 205,444 | 374.64M |
| 389 | ANRO | Alto Neuroscience, Inc. | 923.50M | 4.01% | 60,035 | - |
| 390 | LBRX | LB Pharmaceuticals Inc | 918.51M | 3.32% | 106,270 | - |
| 391 | SLDB | Solid Biosciences Inc. | 915.58M | 4.97% | 256,877 | - |
| 392 | TBPH | Theravance Biopharma, Inc. | 901.66M | 0.58% | 91,424 | 109.78M |
| 393 | ABUS | Arbutus Biopharma Corporation | 900.77M | 3.40% | 665,778 | 191.45M |
| 394 | CERT | Certara, Inc. | 900.72M | 5.46% | 539,715 | 419.75M |
| 395 | EVMN | Evommune, Inc. | 899.74M | 3.52% | 157,430 | 10.00M |
| 396 | GERN | Geron Corporation | 898.13M | 2.19% | 1,897,775 | 196.12M |
| 397 | REPL | Replimune Group, Inc. | 895.91M | -2.52% | 2,168,655 | - |
| 398 | ANNX | Annexon, Inc. | 873.28M | 3.50% | 714,278 | - |
| 399 | VOR | Vor Biopharma Inc. | 872.39M | 7.84% | 323,115 | - |
| 400 | TALK | Talkspace, Inc. | 870.23M | 0.10% | 267,180 | 238.37M |
| 401 | ODTX | Odyssey Therapeutics, Inc. | 867.07M | 1.74% | 27,470 | 1.06M |
| 402 | SPRY | ARS Pharmaceuticals, Inc. | 840.11M | 5.49% | 1,043,521 | 98.99M |
| 403 | DSGN | Design Therapeutics, Inc. | 835.05M | -0.52% | 138,977 | - |
| 404 | PHAT | Phathom Pharmaceuticals, Inc. | 825.28M | 0.48% | 73,692 | 204.89M |
| 405 | BVS | Bioventus Inc. | 822.82M | 1.23% | 160,360 | 576.30M |
| 406 | ESPR | Esperion Therapeutics, Inc. | 812.20M | 0.16% | 1,857,213 | 418.24M |
| 407 | ZVRA | Zevra Therapeutics, Inc. | 809.29M | 3.48% | 171,105 | 122.29M |
| 408 | HSTM | HealthStream, Inc. | 779.02M | 3.75% | 11,819 | 311.78M |
| 409 | CBLL | CeriBell, Inc. | 778.20M | 3.95% | 75,095 | 95.07M |
| 410 | AURA | Aura Biosciences, Inc. | 772.10M | 2.04% | 54,500 | - |
| 411 | GMRS | GMR Solutions Inc. | 771.29M | -2.53% | 63,766 | 5.83B |
| 412 | SIBN | SI-BONE, Inc. | 762.81M | 2.63% | 54,856 | 206.22M |
| 413 | BBNX | Beta Bionics, Inc. | 753.09M | 6.22% | 127,039 | 110.24M |
| 414 | ALLO | Allogene Therapeutics, Inc. | 742.08M | 4.37% | 1,509,812 | 22.00K |
| 415 | CSTL | Castle Biosciences, Inc. | 730.04M | 5.06% | 130,502 | 339.92M |
| 416 | NNNN | Anbio Biotechnology | 722.89M | 2.30% | 1,519 | 8.65M |
| 417 | CTMX | CytomX Therapeutics, Inc. | 720.60M | 1.22% | 357,400 | 35.54M |
| 418 | CLYM | Climb Bio, Inc. | 718.05M | -0.95% | 103,663 | - |
| 419 | RIGL | Rigel Pharmaceuticals, Inc. | 715.29M | 4.51% | 41,048 | 299.77M |
| 420 | CADL | Candel Therapeutics, Inc. | 714.38M | 2.96% | 463,616 | - |
| 421 | OCS | Oculis Holding AG | 706.54M | -0.34% | 40,714 | 1.40M |
| 422 | ACRS | Aclaris Therapeutics, Inc. | 705.30M | 2.85% | 722,710 | 8.37M |
| 423 | IVA | Inventiva S.A. | 703.47M | 2.00% | 204,919 | 7.94M |
| 424 | RLMD | Relmada Therapeutics, Inc. | 700.67M | 3.57% | 304,130 | - |
| 425 | IMMX | Immix Biopharma, Inc. | 697.66M | 0.82% | 464,878 | - |
| 426 | TENX | Tenax Therapeutics, Inc. | 684.12M | 3.88% | 262,567 | - |
| 427 | NVCT | Nuvectis Pharma, Inc. | 683.03M | -7.61% | 299,823 | - |
| 428 | SSII | SS Innovations International, Inc. | 681.93M | -5.87% | 16,343 | 48.47M |
| 429 | IRWD | Ironwood Pharmaceuticals, Inc. | 663.39M | 4.95% | 415,301 | 361.51M |
| 430 | SGP | SpyGlass Pharma, Inc. | 660.31M | 5.00% | 16,127 | - |
| 431 | DNA | Ginkgo Bioworks Holdings, Inc. | 657.82M | 5.22% | 178,447 | 151.40M |
| 432 | TCMD | Tactile Systems Technology, Inc. | 654.24M | 3.59% | 39,019 | 343.52M |
| 433 | AGMB | AgomAb Therapeutics NV | 647.61M | -2.08% | 36,910 | - |
| 434 | FTH | Faeth Therapeutics, Inc. | 639.83M | 0.61% | 30,604 | - |
| 435 | DRUG | Bright Minds Biosciences Inc. | 630.86M | 1.51% | 35,095 | - |
| 436 | SLBT | SL Science Holding Limited | 628.72M | -7.16% | 16,996 | - |
| 437 | OMER | Omeros Corporation | 624.60M | -19.50% | 3,303,720 | 9.89M |
| 438 | FDMT | 4D Molecular Therapeutics, Inc. | 616.34M | 2.34% | 119,751 | 88.24M |
| 439 | CRMD | CorMedix Inc. | 612.71M | 1.17% | 291,994 | 400.05M |
| 440 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 609.62M | -1.04% | 71,025 | - |
| 441 | PRME | Prime Medicine, Inc. | 603.26M | 5.03% | 991,875 | 4.03M |
| 442 | MNPR | Monopar Therapeutics Inc. | 597.87M | 1.85% | 60,827 | - |
| 443 | ACHV | Achieve Life Sciences, Inc. | 593.37M | 1.40% | 415,093 | - |
| 444 | CERS | Cerus Corporation | 593.09M | 3.50% | 739,842 | 216.56M |
| 445 | TECX | Tectonic Therapeutic, Inc. | 592.87M | 1.26% | 30,366 | - |
| 446 | CTKB | Cytek Biosciences, Inc. | 591.47M | 2.46% | 119,474 | 204.17M |
| 447 | BWAY | BrainsWay Ltd. | 590.59M | 1.17% | 9,984 | 56.22M |
| 448 | EVH | Evolent Health, Inc. | 590.53M | 4.37% | 377,743 | 1.89B |
| 449 | CBIO | Crescent Biopharma, Inc. | 588.15M | 4.18% | 16,533 | 11.88M |
| 450 | EIKN | Eikon Therapeutics, Inc. | 587.95M | 10.25% | 39,348 | - |
| 451 | MDXG | MiMedx Group, Inc. | 586.10M | 3.28% | 189,214 | 389.42M |
| 452 | PHR | Phreesia, Inc. | 584.74M | 3.61% | 79,527 | 495.59M |
| 453 | GYRE | Gyre Therapeutics, Inc. | 583.87M | 2.57% | 17,991 | 117.05M |
| 454 | TRAX | First Tracks Biotherapeutics, Inc. | 580.78M | 1.68% | 19,464 | - |
| 455 | NPCE | NeuroPace, Inc. | 579.59M | 3.91% | 22,996 | 99.53M |
| 456 | ANGO | AngioDynamics, Inc. | 563.13M | -1.10% | 146,134 | 313.73M |
| 457 | FLGT | Fulgent Genetics, Inc. | 559.21M | 1.29% | 23,105 | 320.35M |
| 458 | CTEV | Claritev Corporation | 554.71M | -6.28% | 36,289 | 978.76M |
| 459 | AQST | Aquestive Therapeutics, Inc. | 551.98M | -1.46% | 503,871 | 50.27M |
| 460 | ALT | Altimmune, Inc. | 548.42M | -1.74% | 834,521 | 36.00K |
| 461 | PROK | ProKidney Corp. | 548.24M | 6.76% | 198,819 | 889.00K |
| 462 | RGNX | REGENXBIO Inc. | 545.41M | 3.03% | 438,862 | 87.82M |
| 463 | RZLT | Rezolute, Inc. | 536.96M | 2.19% | 391,379 | - |
| 464 | TLRY | Tilray Brands, Inc. | 536.77M | 0.90% | 675,922 | 858.28M |
| 465 | CLPT | ClearPoint Neuro, Inc. | 532.31M | -1.17% | 342,898 | 40.61M |
| 466 | ARVN | Arvinas, Inc. | 531.01M | 2.49% | 182,673 | 89.40M |
| 467 | MYGN | Myriad Genetics, Inc. | 530.33M | 3.41% | 214,903 | 829.00M |
| 468 | XOMA | XOMA Royalty Corporation | 528.98M | -0.05% | 12,106 | 48.56M |
| 469 | CTNM | Contineum Therapeutics, Inc. | 525.09M | 5.13% | 69,162 | - |
| 470 | TOI | The Oncology Institute, Inc. | 524.91M | 2.54% | 191,647 | 545.76M |
| 471 | PACB | Pacific Biosciences of California, Inc. | 518.70M | 4.37% | 2,754,001 | 160.03M |
| 472 | KIDS | OrthoPediatrics Corp. | 511.13M | 1.43% | 81,435 | 243.30M |
| 473 | ASMB | Assembly Biosciences, Inc. | 508.31M | 5.73% | 27,578 | 71.10M |
| 474 | KYTX | Kyverna Therapeutics, Inc. | 507.64M | 1.83% | 184,710 | - |
| 475 | PRTA | Prothena Corporation plc | 506.26M | 4.31% | 67,199 | 57.94M |
| 476 | NGNE | Neurogene Inc. | 505.66M | 5.23% | 36,940 | 925.00K |
| 477 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 478 | SLN | Silence Therapeutics plc | 495.96M | 5.00% | 229,336 | 839.00K |
| 479 | STRO | Sutro Biopharma, Inc. | 494.86M | 1.06% | 50,697 | 99.61M |
| 480 | OCGN | Ocugen, Inc. | 494.24M | 6.57% | 1,949,957 | 4.47M |
| 481 | CCCC | C4 Therapeutics, Inc. | 492.02M | 1.14% | 1,057,174 | 34.86M |
| 482 | STTK | Shattuck Labs, Inc. | 475.42M | 4.91% | 184,624 | 1.00M |
| 483 | SOPH | SOPHiA GENETICS SA | 474.97M | 1.41% | 88,676 | 81.18M |
| 484 | VALN | Valneva SE | 474.76M | -2.69% | 7,656 | 180.25M |
| 485 | OVID | Ovid Therapeutics Inc. | 474.07M | 4.96% | 289,073 | 7.12M |
| 486 | FBRX | Forte Biosciences, Inc. | 473.56M | 3.58% | 19,341 | - |
| 487 | ZURA | Zura Bio Limited | 473.09M | 9.69% | 256,613 | - |
| 488 | EOLS | Evolus, Inc. | 470.53M | -0.07% | 90,885 | 301.79M |
| 489 | VTVT | vTv Therapeutics Inc. | 470.32M | 2.93% | 19,662 | 36.84M |
| 490 | CABA | Cabaletta Bio, Inc. | 469.60M | -1.37% | 1,049,472 | - |
| 491 | NRC | NRC Health | 468.09M | 1.12% | 11,661 | 138.64M |
| 492 | WEAV | Weave Communications, Inc. | 461.48M | 6.42% | 142,640 | 248.72M |
| 493 | SRTA | Strata Critical Medical, Inc. | 458.59M | -1.12% | 317,519 | 228.58M |
| 494 | MOBI | Mobia Medical, Inc. | 457.17M | 5.69% | 36,818 | 38.45M |
| 495 | SI | Shoulder Innovations, Inc. | 455.83M | 1.71% | 33,757 | 53.89M |
| 496 | BNTC | Benitec Biopharma Inc. | 453.99M | 1.65% | 29,187 | - |
| 497 | VMD | Viemed Healthcare, Inc. | 453.14M | 1.11% | 30,356 | 286.57M |
| 498 | EDIT | Editas Medicine, Inc. | 440.44M | 4.74% | 560,612 | 38.69M |
| 499 | ARTV | Artiva Biotherapeutics, Inc. | 439.24M | 2.38% | 54,800 | 251.00K |
| 500 | VREX | Varex Imaging Corporation | 438.32M | 1.07% | 31,927 | 857.50M |